World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT01291290
Date of registration: 07/02/2011
Prospective Registration: No
Primary sponsor: Rigshospitalet, Denmark
Public title: START - Early Thrombocyte Administration to Patients With Ruptured Abdominal Aortic Aneurism rAAA
Scientific title: Thrombocyte Administration Versus no Thrombocytes to Patients With Ruptured Abdominal Aortic Aneurism Before Transport to Hospital With Vascular Surgical Department
Date of first enrolment: March 2010
Target sample size: 420
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT01291290
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment  
Phase:  N/A
Countries of recruitment
Denmark
Contacts
Name:     Henning Bay Nielsen, MD
Address: 
Telephone:
Email:
Affiliation: 
Name:     Thomas Bech Jørgensen, MD
Address: 
Telephone: 25620901
Email: starttrial@gmail.com
Affiliation: 
Name:     Thomas Bech Jørgensen, MD
Address: 
Telephone: 25620901
Email: starttrial@gmail.com
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

- diagnosed with rAAA either by clinical evaluation or CT or UL

Exclusion Criteria:

- formerly randomized in the study

- aneurism not ruptured during operation



Age minimum: N/A
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Ruptured Abdominal Aortic Aneurism
Intervention(s)
Procedure: Platelet
Primary Outcome(s)
Mortality [Time Frame: 30 days]
Secondary Outcome(s)
Post operative kidney failure [Time Frame: 30 days]
Post operative pulmonary insufficiency [Time Frame: 30 days]
Acute myocardial infarction [Time Frame: 30 days]
Length of stay in hospital [Time Frame: until discharged from hospital]
Length of stay in ICU [Time Frame: until discharged from ICU]
Secondary ID(s)
H-D-2009-002
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history